US Patent Issued to Prime Merger Sub on Oct. 7 for "Methods of treating joint disease, disorders, and conditions with tissue inhibitors of matrix metalloproteinase" (Pennsylvania, Oregon Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,918, issued on Oct. 7, was assigned to Prime Merger Sub LLC (Birmingham, Ala.).

"Methods of treating joint disease, disorders, and conditions with tissue inhibitors of matrix metalloproteinase" was invented by Jeffrey S. White (Birchrunville, Pa.) and Robin R. Young (Beaverton, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating joint diseases, disorders, and conditions, such as osteoarthritis, with a composition containing a therapeutically effective amount of tissue inhibitors of matrix metalloproteinases (TIMPs) are provided. The composition can contain TIMPs as part of amniotic fluid, or the TIMPs can be isolated from another...